CAELUS HEALTH
LIVE

Serial Number

79204998

Owner

Caelus Pharmaceuticals B.V.

Attorney

R. Glenn Schroeder

Filing Date

Sep 22, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CAELUS HEALTH Trademark

Serial Number: 79204998 • Registration: 5934509

CAELUS HEALTH is a trademark filed by Caelus Pharmaceuticals B.V. on September 22, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Caelus Pharmaceuticals B.V. (9 trademarks)

Rondweg 50

Entity Type: 98

Trademark Details

Filing Date

September 22, 2016

Registration Date

December 17, 2019

Published for Opposition

October 1, 2019

Cancellation Date

July 3, 2026

Goods & Services

Pharmaceutical preparations for treating cardiometabolic disorders; dietetic foodstuffs adapted for medical use and dietetic substances, namely, dietetic foods adapted for medical use; food supplements for human beings; medical preparations and articles for the treatment of cardiometabolic disorders; pharmaceutical products and natural medicines, both for the treatment of cardiometabolic disorders; pharmaceutical preparations, namely, medicines, for the prevention of diabetes mellitus, Crohn's disease and ulcerative colitis disease; pharmaceutical preparations, namely, medicines for the treatment of diabetes mellitus, Crohn's disease, ulcerative colitis disease and metabolic syndrome being insulin resistance; dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic preparations, namely, dietary supplements; dietary food preparations, namely, dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the prevention of diabetes mellitus, Crohn's disease and ulcerative colitis disease; dietary food preparations, namely, dietetic nutritional food additives for medical purposes in the nature of natural food extracts derived from gut-microbiota and dietetic substances in the nature of dietary supplements for the treatment of diabetes mellitus, Crohn's disease, ulcerative colitis disease and metabolic syndrome being insulin resistance; preparations, namely, cultures of microorganisms for medical use, including bacterial preparations

Medical diagnostic, testing and monitoring equipment, namely, blood testing apparatus for measuring insulin levels and Advanced Glycation Endproducts; medical test kits for home monitoring of diabetes

Filing History

CANCELLED SECTION 71
Jul 3, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 17, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 30, 2023 NREP
NOTIFICATION PROCESSED BY IB
May 1, 2020 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
May 1, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 31, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 30, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 11, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 11, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 22, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 8, 2019 GNFN
FINAL REFUSAL E-MAILED
Jul 8, 2019 GNFR
FINAL REFUSAL WRITTEN
Jul 8, 2019 CNFR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 14, 2018 RCSC
ASSIGNED TO EXAMINER
Dec 12, 2018 DOCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 6, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 19, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 19, 2018 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 14, 2018 RCSC
NEW REPRESENTATIVE AT IB RECEIVED
Dec 15, 2017 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 10, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 10, 2017 GNSL
SUSPENSION LETTER WRITTEN
Dec 10, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2017 CRFA
ASSIGNED TO LIE
Nov 3, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 24, 2017 TROA
REFUSAL PROCESSED BY IB
May 13, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 24, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 24, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 21, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 20, 2017 RFCR
NON-FINAL ACTION WRITTEN
Apr 19, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 17, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 14, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 13, 2017 REPR